NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.

Kidney Neoplasms / therapy Humans Carcinoma, Renal Cell / therapy Clinical Decision-Making

Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
01 11 2019
Historique:
entrez: 7 11 2019
pubmed: 7 11 2019
medline: 14 7 2020
Statut: ppublish

Résumé

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.

Identifiants

DOI: 10.6004/jnccn.2019.0054 PMID: 31693980
pubmed: 31693980
doi: 10.6004/jnccn.2019.0054
pii: jnccnINSKidney1711
doi:
pii:

Types de publication

Journal Article Practice Guideline Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1278-1285

Auteurs

Robert J Motzer (RJ)

Memorial Sloan Kettering Cancer Center.

Eric Jonasch (E)

The University of Texas MD Anderson Cancer Center.

M Dror Michaelson (MD)

Massachusetts General Hospital Cancer Center.

Lakshminarayanan Nandagopal (L)

O'Neal Comprehensive Cancer Center at UAB.

John L Gore (JL)

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Saby George (S)

Roswell Park Comprehensive Cancer Center.

Ajjai Alva (A)

University of Michigan Rogel Cancer Center.

Naomi Haas (N)

Abramson Cancer Center at the University of Pennsylvania.

Michael R Harrison (MR)

Duke Cancer Institute.

Elizabeth R Plimack (ER)

Fox Chase Cancer Center.

Jeffrey Sosman (J)

Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Neeraj Agarwal (N)

Huntsman Cancer Institute at the University of Utah.

Sam Bhayani (S)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Toni K Choueiri (TK)

Dana-Farber/Brigham and Women's Cancer Center.

Brian A Costello (BA)

Mayo Clinic Cancer Center.

Ithaar H Derweesh (IH)

UC San Diego Moores Cancer Center.

Thomas H Gallagher (TH)

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Steven L Hancock (SL)

Stanford Cancer Institute.

Christos Kyriakopoulos (C)

University of Wisconsin Carbone Cancer Center.

Chad LaGrange (C)

Fred & Pamela Buffett Cancer Center.

Elaine T Lam (ET)

University of Colorado Cancer Center.

Clayton Lau (C)

City of Hope National Medical Center.

Bryan Lewis (B)

Kidney Cancer Coalition.

Brandon Manley (B)

Moffitt Cancer Center.

Brittany McCreery (B)

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Andrew McDonald (A)

O'Neal Comprehensive Cancer Center at UAB.

Amir Mortazavi (A)

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Phillip M Pierorazio (PM)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Lee Ponsky (L)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Bruce G Redman (BG)

University of Michigan Rogel Cancer Center.

Bradley Somer (B)

St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

Geoffrey Wile (G)

Vanderbilt-Ingram Cancer Center; and.

Mary A Dwyer (MA)

National Comprehensive Cancer Network.

Lydia J Hammond (LJ)

National Comprehensive Cancer Network.

Griselda Zuccarino-Catania (G)

National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies urogénitales › Maladies urologiques › Tumeurs urologiques › Tumeurs du rein › NCCN Guidelines Insights: Kidney Cancer,...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › NCCN Guidelines Insights: Kidney Cancer,...
questionsmedicales.fr › Maladies urogénitales › Maladies urologiques › Tumeurs urologiques › Tumeurs du rein › Néphrocarcinome › NCCN Guidelines Insights: Kidney Cancer,...
questionsmedicales.fr › Diagnostic › Prise de décision clinique › NCCN Guidelines Insights: Kidney Cancer,...